title: A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases.
abstract: Transcriptional profiling of two isogenic models of transformation identifies a gene signature linking cancer with inflammatory and metabolic diseases. In accord with this common transcriptional program, many drugs used for treatment of diabetes and cardiovascular diseases inhibit transformation and tumor growth. Unexpectedly, lipid metabolism genes are important for transformation and are upregulated in cancer tissues. As in atherosclerosis, oxidized LDL and its receptor OLR1 activate the inflammatory pathway through NF-kappaB, leading to transformation. OLR1 is important for maintaining the transformed state in developmentally diverse cancer cell lines and for tumor growth, suggesting a molecular connection between cancer and atherosclerosis. We suggest that the interplay between this common transcriptional program and cell-type-specific factors gives rise to phenotypically disparate human diseases.
authors.affiliation: Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
authors.forename: Heather A
authors.initials: HA
authors.lastname: Hirsch
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Iliopoulos
authors.forename: Amita
authors.initials: A
authors.lastname: Joshi
authors.forename: Yong
authors.initials: Y
authors.lastname: Zhang
authors.forename: Savina A
authors.initials: SA
authors.lastname: Jaeger
authors.forename: Martha
authors.initials: M
authors.lastname: Bulyk
authors.forename: Philip N
authors.initials: PN
authors.lastname: Tsichlis
authors.forename: X
authors.initials: X
authors.lastname: Shirley Liu
authors.forename: Kevin
authors.initials: K
authors.lastname: Struhl
mesh_terms: D050197:Atherosclerosis / Q000235:genetics*; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D003920:Diabetes Mellitus / Q000235:genetics; D020869:Gene Expression Profiling; D030342:Genetic Diseases, Inborn / Q000235:genetics*; D008040:Genetic Linkage; D014644:Genetic Variation; D006801:Humans; D007249:Inflammation / Q000235:genetics; D024821:Metabolic Syndrome / Q000235:genetics; D009369:Neoplasms / Q000235:genetics*; D009765:Obesity / Q000235:genetics; D051127:Scavenger Receptors, Class E / Q000235:genetics; D014158:Transcription, Genetic
chemical_list: C495137:OLR1 protein, human; D051127:Scavenger Receptors, Class E
references.citation: Neuron. 1991 Aug;7(2):177-81
references.pmid: 1873025
references.citation: Biostatistics. 2003 Apr;4(2):249-64
references.pmid: 12925520
references.citation: Nucleic Acids Res. 2005 Nov 10;33(20):e175
references.pmid: 16284200
references.citation: Cancer Res. 1990 Sep 15;50(18):6075-86
references.pmid: 1975513
references.citation: Cancer Cell. 2007 Feb;11(2):119-32
references.pmid: 17292824
references.citation: Am J Clin Nutr. 2007 Sep;86(3):s836-42
references.pmid: 18265477
references.citation: FEBS Lett. 2008 Jan 9;582(1):81-9
references.pmid: 18022388
references.citation: Curr Opin Genet Dev. 2008 Feb;18(1):19-26
references.pmid: 18440219
references.citation: Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21
references.pmid: 11309499
references.citation: Mol Cell Proteomics. 2006 Sep;5(9):1638-46
references.pmid: 16844680
references.citation: BMC Cancer. 2008 Feb 04;8:41
references.pmid: 18248671
references.citation: Cancer Res. 2003 May 15;63(10):2649-57
references.pmid: 12750293
references.citation: Science. 2005 Dec 9;310(5754):1642-6
references.pmid: 16308421
references.citation: Nat Biotechnol. 2006 Nov;24(11):1429-35
references.pmid: 16998473
references.citation: Physiol Genomics. 2007 Aug 20;30(3):335-41
references.pmid: 17519360
references.citation: J Clin Oncol. 2009 Jul 20;27(21):3437-44
references.pmid: 19470939
references.citation: Nat Rev Cancer. 2007 Apr;7(4):256-69
references.pmid: 17384581
references.citation: Int J Cancer. 2007 Aug 15;121(4):856-62
references.pmid: 17397032
references.citation: Nat Methods. 2008 Apr;5(4):347-53
references.pmid: 18311145
references.citation: Biostatistics. 2007 Jan;8(1):118-27
references.pmid: 16632515
references.citation: Proc Nutr Soc. 2008 May;67(2):128-45
references.pmid: 18412987
references.citation: Cancer Cell. 2008 Aug 12;14(2):156-65
references.pmid: 18691550
references.citation: Cell. 2009 Nov 13;139(4):693-706
references.pmid: 19878981
references.citation: Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):2203-8
references.pmid: 12958047
references.citation: Nature. 1999 Jul 29;400(6743):464-8
references.pmid: 10440377
references.citation: Methods. 2003 Jul;30(3):256-68
references.pmid: 12798140
references.citation: Nature. 2008 Mar 27;452(7186):429-35
references.pmid: 18344982
references.citation: Oncogene. 2007 Dec 13;26(57):7894-903
references.pmid: 17621275
references.citation: Cell. 2008 Jun 27;133(7):1266-76
references.pmid: 18585359
references.citation: Am J Clin Nutr. 2007 Sep;86(3):s867-71
references.pmid: 18265480
references.citation: Cancer Res. 2006 Jun 15;66(12):5977-80
references.pmid: 16778164
references.citation: Nature. 2008 Jul 24;454(7203):436-44
references.pmid: 18650914
references.citation: Lancet. 2001 Feb 17;357(9255):539-45
references.pmid: 11229684
references.citation: Nat Rev Cancer. 2007 Oct;7(10):763-77
references.pmid: 17882277
references.citation: Science. 2009 Jun 26;324(5935):1720-3
references.pmid: 19443739
references.citation: Nature. 2006 May 25;441(7092):431-6
references.pmid: 16724054
references.citation: Nat Genet. 2008 May;40(5):499-507
references.pmid: 18443585
references.citation: Diabetologia. 2005 Sep;48(9):1776-83
references.pmid: 16059715
references.citation: Nat Genet. 2008 Feb;40(2):189-97
references.pmid: 18193044
references.citation: PLoS Genet. 2008 Mar 14;4(3):e1000036
references.pmid: 18369455
references.citation: Cancer Res. 2009 Oct 1;69(19):7507-11
references.pmid: 19752085
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3329-35
references.pmid: 14985505